9 results match your criteria: "Professor of Law at Yale Law School[Affiliation]"
Addressing the Risks That Trade Secret Protections Pose for Health and Rights.
Health Hum Rights
June 2021
Professor of Law at Yale Law School, New Haven, USA, and Faculty Co-Director of the Yale Global Health Partnership and the Law and Political Economy Project.
Human rights frameworks afford everyone the right to health and the right to enjoy the benefits of scientific progress and its applications. Both come together to create state obligations to ensure access to medicines and other health technologies. Though the impact of patents on access to high-quality, affordable medicines and health technologies has been well described, there has been little attention to the impact of trade secrecy law in this context.
View Article and Find Full Text PDFWhy Regulate Guns?
J Law Med Ethics
December 2020
Reva B. Siegel, J.D., M.Phil., is the Nicholas deB. Katzenbach Professor of Law at Yale Law School. Joseph Blocher, J.D., M.Phil., is the Lanty L. Smith '67 Professor of Law at Duke Law School.
Courts reviewing gun laws that burden Second Amendment rights ask how effectively the laws serve public safety - yet typically discuss public safety narrowly, without considering the many dimensions of that interest gun laws serve. "Public safety" is a social good: it includes the public's interest in physical safety as a good in itself, and as a foundation for community and for the exercise of constitutional liberties. Gun laws protect bodies from bullets - and Americans' freedom and confidence to participate in every domain of our shared life, whether to attend school, to shop, to listen to a concert, to gather for prayer, or to assemble in peaceable debate.
View Article and Find Full Text PDFFentanyl: A Whole New World?
J Law Med Ethics
June 2018
Rachel L. Rothberg received her B.A. from Yale College and will receive her J.D. from Yale Law School in May 2019. Kate Stith, J.D., M.P.P., is the Lafayette S. Foster Professor of Law at Yale Law School. She received her B.A. from Dartmouth College, and her M.P.P. and J.D. from Harvard University.
This article seeks to document the latest danger in the opioid crisis: fentanyl and related synthetic opioids. Fifty times more potent than pure heroin, cheaper to manufacture in laboratories worldwide, and easily distributed by mail and couriers, fentanyl is flooding the illicit opioid markets throughout the country.
View Article and Find Full Text PDFThe Opioid Crisis and Federal Criminal Prosecution.
J Law Med Ethics
June 2018
Rachel L. Rothberg received her B.A. from Yale College and will receive her J.D. from Yale Law School in May 2019. Kate Stith, J.D., M.P.P., is the Lafayette S. Foster Professor of Law at Yale Law School. She received her B.A. from Dartmouth College, and her M.P.P. and J.D. from Harvard University.
This article examines how federal law enforcement has responded to the opioid epidemic nationally and in a variety of locales. We focus in depth on two initiatives, including prosecution in opioid-death cases, undertaken by the U.S.
View Article and Find Full Text PDFBuprenorphine MAT as an Imperfect Fix.
J Law Med Ethics
June 2018
Brian Mund, J.D., received his B.A. from the University of Pennsylvania and his J.D. from Yale Law School. Kate Stith, J.D., is the Lafayette S. Foster Professor of Law at Yale Law School. She received her B.A. from Dartmouth College, and her M.P.P. and J.D. from Harvard University.
Expanding buprenorphine access in the United States requires evidence-based decision-making that considers both the drug's potential dangers and its potential benefits. Risks associated with buprenorphine misuse and diversion highlight the need for careful, ongoing evaluation during each stage of increased access.
View Article and Find Full Text PDFGovernment Patent Use to Address the Rising Cost of Naloxone: 28 U.S.C. § 1498 and Evzio.
J Law Med Ethics
June 2018
Alex Wang is a J.D. candidate at Yale Law School. He holds a B.A. from NYU Abu Dhabi, and a second B.A. from the University of Oxford. Aaron S. Kesselheim, M.D., J.D., M.P.H., is an associate professor of medicine at Harvard Medical School and leads the Program On Regulation, Therapeutics, And Law (PORTAL) at Brigham and Women's Hospital. He serves as an Irving S. Ribicoff Visiting Associate Professor of Law at Yale Law School and as a Distinguished Visitor at the Solomon Center for Health Law & Policy.
The rising cost of the opioid antagonist and overdose reversal agent naloxone is an urgent public health problem. The recent and dramatic price increase of Evzio, a naloxone auto-injector produced by Kaléo, shows how pharmaceutical manufacturers entering the naloxone marketplace rely on market exclusivity guaranteed by the patent system to charge prices at what the market can bear, which can restrict access to life-saving medication. We argue that 28 U.
View Article and Find Full Text PDFThe Role of Civil Commitment in the Opioid Crisis.
J Law Med Ethics
June 2018
Ish Prasad Bhalla, M.D., is a fellow in forensic psychiatry in the Department of Psychiatry, Yale School of Medicine. He received his B.S. from Case Western Reserve University and his M.D. from University of Toledo College of Medicine. Nina Cohen, J.D., received her A.B. from Bryn Mawr College and her MSc from the University of Oxford. She received her J.D. from Yale Law School in May 2018. Claudia E. Haupt, Ph.D., J.S.D., is a Resident Fellow at the Information Society Project and a Research Fellow at the Solomon Center for Health Law & Policy, both at Yale Law School. She received her first law degree and Ph.D. from the University of Cologne, her LL.M. from George Washington University, and her J.S.D. from Columbia Law School. Kate Stith, J.D., is the Lafayette S. Foster Professor of Law at Yale Law School. She received her B.A. from Dartmouth College, and her M.P.P. and J.D. from Harvard University. Rocksheng Zhong, M.D., M.H.S., is a fellow in forensic psychiatry in the Department of Psychiatry, Yale School of Medicine. He received his A.B. from Harvard College and his M.D. and M.H.S. from the Yale School of Medicine.
Article Synopsis
- This article talks about how civil commitment (like helping people with serious drug problems) relates to the opioid crisis, which is a big issue with painkillers.
- It explains the current laws and rules about civil commitment and what they mean for people who need help.
- The article discusses important things that lawmakers need to think about, like medical, moral, and legal issues, to find the best ways to respond to the crisis.
Introduction.
J Law Med Ethics
June 2018
Ian Ayres, J.D., Ph.D., is the William K. Townsend Professor at Yale Law School. He received his Ph.D. (Economics) from M.I.T. and his J.D. from Yale. Abbe R. Gluck, J. D., is Professor of Law and Faculty Director, Solomon Center for Health Law and Policy, Yale Law School. She received her B.A. and J.D. from Yale. Kate Stith, J.D., M.P.P., is the Lafayette S. Foster Professor of Law at Yale Law School. She received her B.A. (Economics) from Dartmouth and her M.P.P. and J.D. from Harvard.
'Government Patent Use': A Legal Approach To Reducing Drug Spending.
Health Aff (Millwood)
May 2016
Aaron S. Kesselheim is an associate professor of medicine at Harvard Medical School and director of the Program on Regulation, Therapeutics, and Law, Division of Pharmacoepidemiology and Pharmacoeconomics, at Brigham and Women's Hospital, in Boston, Massachusetts.
Article Synopsis
- High costs of patent-protected brand-name drugs, like hepatitis C treatments, limit patient access and can lead to serious health complications due to prescribing restrictions by insurers.
- The proposal is for the federal government to utilize "government patent use" laws to obtain generic versions of these drugs, paying patent holders reasonable royalties, making treatments more accessible.
- This approach could significantly decrease treatment costs, allowing more patients access to necessary medications while reducing monopoly profits from pharmaceutical companies.